- Rockwell Medical ( NASDAQ: RMTI ) has risen 7% after the company posted better-than-expected results, helped by strong sales of blood disorder drugs.
- Rockwell reported Q2 loss of $0.56, that beat by $0.25, while revenue rose 23% Y/Y to $18.68M, which beat by $1.88M and was the highest quarterly revenue to-date for Rockwell
- The company said it had raised $30M during the second quarter.
- Cash used in operating activities for the three months ended June 30, was $5.8M, compared to $9.8M, a year earlier, a 40% decrease.
- Stock has fallen ~60% YTD.
- Transcript
For further details see:
Rockwell Medical rises 7% on strong Q2 result